For Good Science, You Need Engaged Citizens
By Gregory E. Kaebnick, Michael K. Gusmano,
Scientific American
| 07. 22. 2021
They strengthen the institutions that ensure a strong democracy, leading to rational decisions
Photo by Mika Baumeister on Unsplash
The White House has rehired a climate scientist who was forced out by the Trump administration, and is proposing to dramatically increase the budget of the Centers for Disease Control and Prevention. “Science is back” has become a Biden slogan. But listening to scientists is only the first step—and only a partial step, given the deep distrust many Americans have for experts. We must improve how ordinary citizens help shape science policy.
This is one of the findings of a recent report from the Hastings Center that examines the role of citizens in shaping policy in health and science. That role should not be limited to electing candidates and then, a few years later, expressing approval or disapproval of their job performance. Too many issues are in play at once for the voting–governing connection to be meaningful for many of them, and most people do not choose candidates on the basis of a clear understanding of policies, anyway
It is unlikely, for example, that elections will provide guidance about the governance...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...